Stay updated on Semaglutide with Lifestyle Program: Weight Lowering Clinical Trial
Sign up to get notified when there's something new on the Semaglutide with Lifestyle Program: Weight Lowering Clinical Trial page.

Latest updates to the Semaglutide with Lifestyle Program: Weight Lowering Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page adds a Show glossary toggle and makes minor text updates, including capitalization changes for 'Last Update Submitted that Met QC Criteria' and the footer items 'No FEAR Act Data' and 'Revision: v3.4.0'. These changes do not alter the study details.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.0%

- Check48 days agoChange DetectedAdded a new Locations section listing participating states (Alabama, Arizona, California, Colorado, Florida, Georgia, Hawaii, Illinois, New York, North Carolina, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, Washington) and updated the page revision to v3.3.3. Individual state location subsections were removed, and the HHS Vulnerability Disclosure section was deleted.SummaryDifference1%

- Check70 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing Revision: v3.3.1. This is a minor metadata update.SummaryDifference0.0%

- Check77 days agoChange DetectedTwo new publication descriptions were added to clarify voluntariness and automatic PubMed auto-fill, and the Publication section wording was streamlined, including a Revision: v3.3.1 tag.SummaryDifference0.1%

- Check84 days agoChange DetectedThe government funding lapse notice was removed from the page, eliminating the message about potential data unavailability and links to cc.nih.gov and opm.gov.SummaryDifference0.3%

Stay in the know with updates to Semaglutide with Lifestyle Program: Weight Lowering Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide with Lifestyle Program: Weight Lowering Clinical Trial page.